preview

Skeletal Muscle Contraction

Decent Essays

Neuromuscular junctions play a key role in skeletal muscle contractions, and they consist of axon terminals, synaptic clefts, and junctional folds. The contraction begins with the arrival of a nerve impulse at an axon terminal which causes acetylcholine (ACh) to be released into the synaptic cleft. ACh then diffuses across the synaptic cleft and binds with receptors on the sarcolemma of skeletal muscles. This binding creates electrical events that allow an action potential through muscle fiber which causes a muscle contraction. However, normal communication between a muscle and nerve can be interrupted due to the neurological disorder, myasthenia gravis. In Latin and Greek, Myasthenia gravis means “grave muscle weakness,” (fact sheet). As stated …show more content…

Antibodies not only block or destroy ACh receptor cites, but they can also block a protein called tyrosine kinase that is involved in forming the neuromuscular junction; furthermore, researchers believe that the thymus gland can trigger or maintain the production of antibodies that block ACh. (National Institute of Neurological Disorders and Stroke [NINDS], 2016) Myasthenia gravis also leads to muscle weakness and it can affect any of the voluntary muscles which include facial and limb muscles. This disorder begins with the muscles in the face; some of the symptoms include: eye problems such as drooping of the eyelids and double vision, face and throat muscle problems such as altered speaking, dyspnea, chewing problems and limited facial expressions, and weakness in the neck, arms and legs (Mayo Clinic Staff, 2016). Myasthenia gravis can worsen if person with this disorder is exposed to bright sunlight, immunization, surgery, emotional stress, menstruation, illnesses, and medications such as beta-blockers and statins (Shah & Goldenberg, …show more content…

A study was conducted from January 2005 to January 2010 in order to determine if the presence of myasthenia gravis affected the prognosis of patients that underwent an extended thymectomy. The study consisted of 104 patients (61 men, 43 women, and 38 of these patients had myasthenia gravis with the average age being about 55 years old) with thymoma. According to Zhefeng et. al., myasthenia gravis complicates a significant amount of thymomas, and the primary treatment method for thymomas are extended thymectomies (2016). 11 patients faced a reappearance of a thymoma or suffered to respiratory failure due to myasthenia gravis during this five-year study period. The survival rate for patients with myasthenia gravis was 76%, and 89.1% in patients without myasthenia gravis. In conclusion, patients with thymomas and myasthenia gravis had a poorer prognosis than patients with thymomas without myasthenia gravis (Zhefeng et al.). Another study was conducted from 1999 to 2014 to describe the outcomes of patients with myasthenia gravis that had gone through a thymectomy. The patients in this study were 12 children (under 18 years of age) that had a thymectomy at Phoenix Children’s Hospital. The time for the patients’ hospital stay ranged from one to five days, and after a month these children did not contract an illness or faced death. This

Get Access